Supriya Life Sciences Profit & Loss Annual

BSE: 543434 | NSE: SUPRIYA | ISIN: INE07RO01027 | Sector: Biotechnology & Drugs

792.40 -9.40 (-1.17%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	570.37	460.94	530.05	385.37
Total Revenue	570.37	460.94	530.05	385.37
Costof Revenue Total	221.74	206.98	213.75	140.54
Gross Profit	348.63	253.96	316.30	244.83
Selling/ General/ Admin Expenses Total	67.64	114.77	97.72	75.22
Depreciation/ Amortization	15.81	11.82	10.12	6.76
Other Operating Expenses Total	108.02	2.29	2.79	1.57
Total Operating Expense	413.21	343.77	325.71	224.72
Operating Income	157.17	117.17	204.34	160.64
Interest Inc( Exp) Net- Non- Op Total	-21.10	78.65	43.64	44.77
Other Net	10.64	-1.43	-1.46	2.27
Net Income Before Taxes	165.69	123.49	207.25	167.39
Provisionfor Income Taxes	46.58	33.63	55.44	43.57
Net Income After Taxes	119.11	89.86	151.81	123.83
Net Income Before Extra Items	119.11	89.86	151.81	123.83
Net Income	119.11	89.86	151.81	123.83
Income Availableto Com Excl Extra Ord	119.11	89.86	151.81	123.83
Income Availableto Com Incl Extra Ord	119.11	89.86	151.81	123.83
Diluted Net Income	119.11	89.86	151.81	123.83
Diluted Weighted Average Shares	8.05	8.05	8.05	8.05
Diluted EPS Excluding Extra Ord Items	14.80	11.16	18.86	15.39
DPS- Common Stock Primary Issue	0.80	0.60	0.60	0.00
Diluted Normalized EPS	14.80	11.78	18.83	15.39
Research Development	-	12.37	16.62	6.61
Unusual Expense( Income)	-	6.67	-0.34	-0.03
Gain( Loss)on Saleof Assets	-	-1.11	-	0.00